Comparison of human papillomavirus distribution in cytologic subgroups of low-grade squamous intraepithelial lesion

Cancer

Volumn 108, Issue 5, 2006, Pages 288-297

  Zuna, Rosemary E ^a   Wang, Sophia S ^b   Schiffman, Mark ^b   Solomon, Diane ^b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Cervical cancer screening; Cervical intraepithelial neoplasia Grade 1; Human papillomavirus; Koilocytotic atypia; Low grade squamous intraepithelial lesion; Papanicolaou test

Indexed keywords

ADVANCED CANCER; BLOTTING; CANCER CENTER; CANCER CYTODIAGNOSIS; CANCER GRADING; CANCER RISK; COMPARATIVE STUDY; DEVICE; DIAGNOSTIC VALUE; EARLY CANCER; FEMALE; FOLLOW UP; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; LABORATORY; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PATIENT REFERRAL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS DETECTION; VIRUS TYPING; WART VIRUS;

CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY, SURGICAL; PRECANCEROUS CONDITIONS; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33750079231     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22168     Document Type: Review

References (36)

1. Koss LG, Durfee GR. Unusual patterns of squamous epithelium of the uterine cervix: cytologic and pathologic study of koilocytotic atypia. Ann NY Acad Sci. 1956;63:1245-1261.
2. Ayre JE. Role of the halo cell in cervical carcinogenesis: a virus manifestation or premalignancy? Obstet Gynecol 1960;17:175-182.
3. Meisels A, Fortin R. Condylomatous lesions of the cervix and vagina. I. Cytologic patterns. Acta Cytol. 1976;20:505-509.
4. Meisels A, Fortin R, Roy M. Condylomatous lesions of the cervix: II. Cytologic, colposcopic and histopathologic study. Acta Cytol. 1977;21:379-390.
5. Schiffman MH, Bauer HM, Hoover RN, et al. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993;85:958-964.
6. Bosch FX, Manos MM, Munoz N, et al. Prevalence of human papillomavirus DNA in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBBSCC) Study Group. J Natl Cancer Inst. 1995;87:796-802.
7. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19.
8. Kuhler-Obbarius C, Milde-Langosch K, Loning T, Stegner HE. Polymerase chain reaction-assisted evaluation of low and high grade squamous intraepithelial lesion cytology and reappraisal of the Bethesda System. Acta Cytol. 1994;38:681-686.
9. Casas-Cordero M, Morin C, Roy M, Fortier M, Meisels. Origin of the koilocyte in condylomata of the human cervix: ultrastructural study, Acta Cytol. 1981;25:383-392.
10. Morin C, Meisels A. Human papilloma virus infection of the uterine cervix. Acta Cytol. 1980;24:82-94.
11. Recher L, Strebnik. Histopathologic features of koilocytotic atypia: a detailed description. Acta Cytol. 1981;25:377-382.
12. Jenson AB, Kurman RJ, Lancaster WD. Tissue effects of and host response to human papillomavirus infection. Dermatol Clin. 1991;9:203-209.
13. Ziol M, Di Tomaso C, Biaggi A, et al. Virological and biological characteristics of cervical intraepithelial neoplasia Grade 1 with marked koilocytotic atypia. Hum Pathol 1998;29:1068-1073.
14. Sherman ME, Schiffman MH, Erozan YS, Wacholder S, Kurman RJ. The Bethesda System. A proposal for reporting abnormal cervical smears based on the reproducibility of cytopathologic diagnoses. Arch Pathol Lab Med. 1992;116:1155-1158.
15. Lee KR, Minter LJ, Crum CP. Koilocytotic atypia in Papanicolaou smears: reproducibility and biopsy correlations. Cancer (Cancer Cytopathol). 1997;81:10-15.
16. Kurman RJ, Malkasian GD, Sedlis A, Solomon D. From Papanicolaou to Bethesda: the rationale for a new cervical cytologic classification. Obstet Gynecol. 1991;77:779-782.
17. Kurman RJ, Solomon D. The Bethesda System for Reporting Cervical/Vaginal Cytologic Diagnoses: Definitions, Criteria, and Explanatory Notes for Terminology and Specimen Adequacy. New York: Springer-Verlag; 1994.
18. Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287:2114-2119.
19. Clifford GM, Smith JS, Aguado , Franceschi S. Comparison of HPV type distribution in high grade lesions and cervical cancer: a meta-analysis. Br J Cancer. 2003;89:101-105.
20. Munoz N, Bosch FX, de Sanjose S, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003;348:518-527.
21. Cogliano V Baan R, Straif K, et al., World Health Organization International Agency for Research on Cancer. Carcinogenicity of human papillomaviruses. Lancet Oncol. 2005;6:204. Abstract.
22. Schiffman M, Adrianza ME. ASCUS-LSIL Triage Study. Design, methods and characteristics of trial participants. Acta Cytol. 2000;44:726-742.
23. Zuna RE, Wang SS, Rosenthal DL, Jeronimo J, Schiffman M, Solomon D. Determinants of human papillomavirus (HPV) negative low grade squamous intraepithelial lesions (LSIL) in the ASCUS LSIL Triage Study (ALTS). Cancer (Cancer Cytopathol). 2005;105:253-262.
24. [No authors listed.] Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. The Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesions Triage Study (ALTS) Group. J Natl Cancer Inst. 2000;92:397-402.
25. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol. 1998;36:3020-3027.
26. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol. 2000;38:357-361.
27. Bavin PJ, Giles JA, Deery A, et al. Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. Br J Cancer. 1993;67:602-605.
28. Sherman ME, Schiffman M, Cox JT. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized Atypical Squamous Cells of Undetermined Significance/Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS). J Natl Cancer Inst. 2002;94:102-107.
29. Schiffman M, Wheeler CM, Dasgupta A, Solomon D, Castle PE, for the ALTS Group. A comparison of a prototype PCR assay and Hybrid Capture 2 for detection of carcinogenic human papillomavirus DNA in women with equivocal or mildly abnormal Papanicolaou smears. Am J Clin Pathol. 2005;124:722-732.
30. Wright TC, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA. 2002;287:2120-2129.
31. Gissman L, Wolnik L, Ikenberg H, Koldovsky U, Schnurch HG, zur Hausen H. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA. 1983;80:560-563.
32. Kadish AS, Hagan RJ, Ritter DB, et al. Biologic characteristics of specific human papillomavirus types predicted from morphology of cervical lesions. Hum Pathol. 1992;23:1262-1269.
33. Jovanovic AS, McLachlin CM, Shen L, Welch WR, Crum CP. Postmenopausal squamous atypia: a spectrum including "pseudokoilocytosis." Mod Pathol. 1995;8:408-412.
34. Woodhouse SL, Stastny JF, Styer PE, Kennedy M, Praestgaard AH, Davey DD. Interobserver variability in subclassification of squamous intraepithelial lesions: results of the College of American Pathologist Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med. 1999;123:1079-1084.
35. Stoler MH, Schiffman M. Atypical Squamous Cells of Undetermined Signiflcance-Low-Grade Squamous Intraepithelial Lesion Triage Study (ALTS) Group. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA. 2001;285:1500-1505.
36. Castle PE, Schiffman M, Burk RD, et al. Restricted cross-reactivity of Hybrid Capture-2 with noncarcinogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev. 2002;11:1394-1399.